Literature DB >> 9696567

Interaction of taxol and other anticancer drugs with alpha-cyclodextrin.

T Cserháti1, E Forgács, J Holló.   

Abstract

The interaction between 23 anticancer drugs and alpha-cyclodextrin (alpha-CD) was studied by reversed-phase charge-transfer thin-layer chromatography and the relative strength of interaction was calculated. As alpha-CD has smaller cavity than beta- and tau-CD it interacted only with 10 anticancer drugs proving the relatively poor complex forming capacity of alpha-CD. The hydrophobicity of host-guest inclusion complex was always different from that of the uncomplexed drug suggesting that the complex formation may influence the uptake, absorption, half-life etc. of the original drug. The inclusion forming capacity of drugs differed considerably according to their chemical structure. The intensity of interaction significantly depended on the hydrophobicity of the guest molecule proving the preponderant role of hydrophobic interactions in inclusion complex formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9696567     DOI: 10.1016/0731-7085(95)01263-k

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Molecular Inclusion Complexes of β-Cyclodextrin Derivatives Enhance Aqueous Solubility and Cellular Internalization of Paclitaxel: Preformulation and In vitro Assessments.

Authors:  Milin Shah; Vatsal Shah; Anasuya Ghosh; Zheng Zhang; Tamara Minko
Journal:  J Pharm Pharmacol (Los Angel)       Date:  2015-01-10

2.  Designing Paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges.

Authors:  Madhu S Surapaneni; Sudip K Das; Nandita G Das
Journal:  ISRN Pharmacol       Date:  2012-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.